Canadian Biotech Stocks Performing Well Are Under the Radar, Says Portfolio Manager

Share on Linkedin

Next Edge Capital Corp. Portfolio Manager Eden Rahim provides advice for investors wanting to buy Canadian biotech stocks


Next Edge Capital Corp. Portfolio Manager Eden Rahim, in this interview with SmallCapPower at the Bloom Burton Healthcare Investor Conference in Toronto, says he believes Canadian biotech stocks bottomed about a year ago and goes on to outline what he looks for in a biotech stock before investing. He also offers up some advice for investors wanting to buy into the sector.

For more video coverage from the Bloom Burton Healthcare Investor Conference please click here

Disclosure: The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: